dotMD.com
High Blood Pressure & Vascular Health • ICD-10-CM I80.3

Phlebitis and thrombophlebitis of lower extremities

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM I80.3 • 4 Linked .gov / PubMed Citations • Governance: Dr. Marcus Thorne, MD, FACC (NPI #1184629314)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Phlebitis and thrombophlebitis of lower extremities Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Phlebitis and thrombophlebitis of lower extremities

3 of 3 Free Questions Remaining

What Is Phlebitis and thrombophlebitis of lower extremities?

For patients presenting with Phlebitis and thrombophlebitis of lower extremities (ICD-10-CM I80.3), High Blood Pressure & Vascular Health protocols prioritize segmental arterial Doppler in Phlebitis and thrombophlebitis of lower extremities (I80.3: waveforms) paired with baseline and interval Serum Creatinine & in Phlebitis and thrombophlebitis of lower extremities (I80.3: Potassium) assessment.

Pathophysiology, Underlying Causes & Clinical Presentation

Phlebitis and thrombophlebitis of lower extremities (I80.3) alters blood pressure homeostasis through venous valve incompetence [Phlebitis and thrombophlebitis of lower extremities I80.3]; clinical remission targets Urine Albumin-to-Creatinine Ratio [Phlebitis and thrombophlebitis of lower extremities I80.3] within < 15 mg/g (I80.3).

Common Symptoms & Clinical Signs

  • • Presentation of Phlebitis and thrombophlebitis of lower extremities (I80.3): localized extremity swelling, in Phlebitis and thrombophlebitis of lower extremities (I80.3: warmth, or venous)
  • • Secondary Phlebitis and thrombophlebitis of lower extremities clinical sign: cold distal extremities in Phlebitis and thrombophlebitis of lower extremities (I80.3: or diminished peripheral)
  • • Symptom flares in Phlebitis and thrombophlebitis of lower extremities correlating with Serum Creatinine & in Phlebitis and thrombophlebitis of lower extremities (I80.3: Potassium) deviation outside K+ 4.0 – 4.8 mEq/L (I80.3)
  • • Functional blood pressure impact requiring segmental arterial Doppler in Phlebitis and thrombophlebitis of lower extremities (I80.3: waveforms) evaluation (I80.3)

Phlebitis and thrombophlebitis of lower extremities Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code I80.3 WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub High Blood Pressure & Vascular Health NLM Clinical Tables
Diagnostic / Lab Marker: Serum Creatinine & in Phlebitis and thrombophlebitis of lower extremities (I80.3: Potassium) K+ 4.0 – 4.8 mEq/L (I80.3) Clinical Reference Target Range
Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Phlebitis and thrombophlebitis of lower extremities I80.3] < 15 mg/g (I80.3) Clinical Reference Target Range
Diagnostic / Lab Marker: Home Seated Blood in Phlebitis and thrombophlebitis of lower extremities (I80.3: Pressure) < 120/75 mmHg (I80.3) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Phlebitis and thrombophlebitis of lower extremities

Check Drug Interactions →
Medication Pharmacologic Class Patient Worth-It CMS NADAC / Unit Typical Lowest Cash
Phenazopyridine Hydrochloride Uqora Maximum Uti Pain Relief, Urinary Pain Relief • RxCUI 1094104 Over-the-Counter Clinical Monograph 92% $0.1748 $ 15.58 /mo
Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Phlebitis and thrombophlebitis of lower extremities)

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
Can This Approach Help? Inside the Latest Research on Pharmacoepigenetics of high blood pressure: genome-wide methylation analysis of

The single-drug treatment groups consisted of approximately 200 individuals each.

Epigenetics • 2022-11-15 • Randomized Controlled Trial
Multi-cohort 88/100 PMID 35213289 ↗
What the Latest Evidence Really Says About Effect of tirzepatide and semaglutide on blood

Tirzepatide reduces high blood pressure-related side effects but increases dose-dependent hypotension risk in patients with T2DM or obesity.

Endocrine • 2026-08-15 • Meta-Analysis
Multi-cohort 86/100 PMID 42603240 ↗
Zero-PHI Patient Support & Cohort Discussions

Phlebitis and thrombophlebitis of lower extremities Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Phlebitis and thrombophlebitis of lower extremities community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Phlebitis and thrombophlebitis of lower extremities.

Related Conditions in High Blood Pressure & Vascular Health